Liver disease in the capital rose by 23% between 2007 and 2008, higher than in any other part of the UK. Under current practices, less than 50% of patients undergo surgery. The PASSPORT project’s virtual liver could considerably increase this percentage.
First results of the project clearly demonstrate the cost effectiveness and benefits of patient-specific surgical planning. The next step is making the software commercially available. This commercialisation will be a first step towards the routine clinical use of PASSPORT results.
Using EU-research funding to help improve citizens’ lives, medical knowledge, and enable high-tech industries are among the goals of the Digital Agenda for Europe.